Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables

Heart

Volumn 87, Issue 3, 2002, Pages 235-241

  Juenger, Jana ^a   Schellberg, D ^a   Kraemer, S ^a   Haunstetter, A ^a   Zugck, C ^a   Herzog, W ^a   Haass, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC HEPATITIS; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GERMANY; HEMODIALYSIS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0036183612     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.3.235     Document Type: Article

References (40)

1. Health related quality of life and subjective health. Overview of the status of research for new evaluation criteria in medicine
2. Quality of life: Can it and should it be assessed in patients with heart failure?
3. Assessment of quality of life in clinical trials of cardiovascular therapies
4. Patient's self-assessment of their congestive heart failure. Part 2. Content, reliability and validity of a new measure, the Minnesota living with heart failure questionnaire
5. Validity of the Minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo
6. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The pimobendan multicenter research group
7. Safety and efficacy of carvedilol in severe heart failure
8. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: A preliminary study
9. Improving outcomes in congestive heart failure: VaI-HeFT. Valsartan in Heart Failure trial
10. The left ventricular dysfunction questionnaire (LVD·36): Reliability, validity, and responsiveness
11. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure
12. Measurement of health-related quality of life in heart failure
13. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts)
14. Burden and outcomes of hospitalisation far congestive heart failure
15. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
16. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
17. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity
18. Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy
19. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy
20. Is the six minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
21. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure
22. Der Deutsche SF-36 health survey
23. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
24. Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment
25. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups
26. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study
27. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: A two-years follow-up study
28. Prevalence of depression in congestive heart failure
29. Quality of life, anxiety and depression dependent on NYHA-class in patients with chronic heart failure
30. Cerebrovascular reactivity is impaired in patients with cardiac failure
31. Assessment of quality of life as observed from the baseline data of the studies of left ventricular dysfunction (SOLVD) trial quality-of-life substudy
32. Quality of life in patients with advanced heart failure
33. Beta blocker treatment in heart failure
34. Effects of exercise training in patients with congestive heart failure: A critical review
35. Circulatory status and response to cardiac rehabilitation in patients with heart failure
36. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
37. Hopelessness depression: A theory-based subtype of depression
38. Depressogenic cognitive styles: Predictive validity, information processing and personality characteristics, and developmental origins
39. The epidemiology of heart failure